The Pharma Letter Pharmaletter News Articles
Mundipharma identifies barriers to market access, offers solutions
A research paper sponsored by UK-based Mundipharma International together with the University of Cambridge…
US Reps launch investigation of Pharma’s skyrocketing prices for MS drugs
In the USA, Representatives Elijah Cummings (Democrat, Maryland), a Ranking Member of the House Committee…
NICE gives provisional thumbs down to two thyroid cancer treatments
The UK’s health technology assessor has provided draft guidance which does not recommend Cometriq or…
Janssen opposes use of drug in lethal injection
The US state of Florida’s plans to use a drug invented by Janssen, the pharma arm of healthcare giant…
UK trade group lobbies for £140 million investment in biotech industry
The Medicines Manufacturing Industry Partnership has issued a report seeking government support for the…
Takeda files for vedolizumab approval in Japan
Takeda Pharmaceutical has submitted a New Drug Application to the Ministry of Health, Labor and Welfare…
Strengthening EU-US cooperation in medicine inspections
The European Commission, the US Food and Drug Administration and the European Medicines Agency have signed…
EC investigates Bayer’s bid for Monsanto
A $66 billion takeover bid for a US agriculture firm from German life sciences company Bayer is being…
Depression drug taken forward despite trial failures
Alkermes will hope that the US Food and Drug Administration (FDA) ignores the failure of two Phase III…
Merck Ventures adds to series A investment in Macrophage Pharma
Merck Ventures, the venture capital arm of the German pharmaceutical group Merck KGaA has invested in…
Encore Dermatology gets rights to psoriasis drug DFD-06
Dr Reddy’s Laboratories, through its wholly-owned US subsidiary Promius Pharma, has out-licensed the…
Scientists uncover a deadly ‘addiction’ in esophageal cancer
Scientists have discovered a new way of attacking esophageal cancer cells that could make use of an existing…
FDA stresses importance of act that affirms USA as ‘leader in biomedical innovation’
While the signing of the Food and Drug Administration Reauthorization Act of 2017 (FDARA) was not the…
Hamburg-based biotech agrees R&D collaboration with Eli Lilly
Privately-held Topas Therapeutics, a spin-out from German biotech firm Evotec, has agreed a multi-year…
Are we on the verge of a biosimilars breakthrough in the USA£
A total of 32 biosimilar products, based on 12 biologics, have been approved for use in the European…
MHRA backs gene therapy in battle with 'bubble baby' disease
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a Promising Innovative…
Indian Patent Office at last approves Pfizer’s patent for Prevnar 13
The Indian Patent Office has granted US drug giant Pfizer (NYSE: PFE) a patent for its blockbuster vaccine,…
Industry praise for Brexit pragmatism
The drug development industry has welcomed the UK government’s position paper seeking a smooth and…
Xellia Pharma completes $13 million Hungarian plant expansion
Danish specialty pharma firm Xellia Pharmaceuticals has completed the expansion of its new $13 million,…
Samsung Bioepis answers biologics question with resounding ‘yes’
There is little doubt that, since it started life in the drug development industry just five years ago,…
Ron Menezes takes over as president of Almirall’s US subsidiary Aqua Pharma
Almirall has appointed Ron Menezes as the new president and general manager of its USA-based subsidiary…
'Writing on the wall' suggests progress in ALS may be imminent, says Cytokinetics CEO
San Franciscan firm Cytokinetics is pursuing an unusual angle to therapeutic discovery, starting from…
OptiBiotix and Sacco in global push to access probiotics market
OptiBiotix Health has expanded the terms of a manufacturing, supply and profit sharing deal agreed with…
The legal and regulatory challenges of getting a biosimilar product to market
After a pharma view on biosimilars was provided in our previous Expert View column, a legal perspective…
Ironwood cleared to market dual gout therapy in the USA
USA-based Ironwood Pharmaceuticals has been handed approval to market its gout therapy Duzallo (allopurinol…
Artificial intelligence firm hires ex-GSK exec to lead drug discovery
UK-based artificial intelligence firm BenevolentAI has hired Ian Churcher as VP of drug discovery & preclinical…
Janssen collaborates with Australian institute on Alzheimer’s disease research
Australia’s St Vincent’s Institute of Medical Research (SVI) in Melbourne, has entered into a collaboration…
FDA evaluating prescription opioid medications approved to treat cough in children
US Food and Drug Administration Commissioner Scott Gottlieb says there’s perhaps no more important…
Significant increase in pharmaceutical substances imports this year in Russia
Russian drugmakers and foreign companies operating in the country have significantly increased the volume…
Teva next to launch generic testosterone solution in USA
Israel’s Teva Pharmaceutical Industries has launched a generic version of Axiron (testosterone) topical…
Feed Fetched by RSS Dog.